Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association between elevated white blood cell counts and thrombotic events in polycythemia vera: analysis from REVEAL
Aaron T. Gerds, Ruben A. Mesa, John M. Burke, et al.
Blood (2023) Vol. 143, Iss. 16, pp. 1646-1655
Open Access | Times Cited: 19

Showing 19 citing articles:

Clinical impact of mutated JAK2 allele burden reduction in polycythemia vera and essential thrombocythemia
Paola Guglielmelli, Barbara Mora, Francesca Gesullo, et al.
American Journal of Hematology (2024) Vol. 99, Iss. 8, pp. 1550-1559
Closed Access | Times Cited: 11
Diagnosis and Treatment of Polycythemia Vera
Douglas Tremblay, Marina Kremyanskaya, John O. Mascarenhas, et al.
JAMA (2024)
Closed Access | Times Cited: 5
Thrombosis‐Driven Disease Progression in JAK2‐Mutant Polycythemia Vera and Essential Thrombocythemia: Reassessing Risk‐Based Management
Tiziano Barbui, Valerio De Stefano, Elena Rossi, et al.
American Journal of Hematology (2025)
Closed Access
Impact of treatment for adolescent and young adults with essential thrombocythemia and polycythemia vera
Yan Beauverd, Jean‐Christophe Ianotto, Kyaw Htin Thaw, et al.
Leukemia (2025)
Open Access
Efficacy and safety outcomes in Japanese patients with low-risk polycythemia vera treated with ropeginterferon alfa-2b
Kazuya Shimoda, Albert Qin, Norio Komatsu, et al.
International Journal of Hematology (2024) Vol. 120, Iss. 2, pp. 151-156
Open Access | Times Cited: 3
High red cell mass and high plasma volume are independently associated with thrombotic risk in polycythemia vera
Ivan Krečak, Danijela Leković, Andrija Bogdanović, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2024) Vol. 65, Iss. 11, pp. 1724-1728
Closed Access | Times Cited: 2
Neutrophil/lymphocyte ratio identifies low‐risk polycythaemia vera patients for early Ropeginterferon alfa‐2b therapy
Tiziano Barbui, Alessandra Carobbio, Paola Guglielmelli, et al.
British Journal of Haematology (2024)
Closed Access | Times Cited: 2
Efficient white blood cell identification with hybrid inception-xception network
Radhwan A. A. Saleh, Mustafa Ghaleb, Wasswa Shafik, et al.
The Journal of Supercomputing (2024) Vol. 80, Iss. 17, pp. 25155-25187
Closed Access | Times Cited: 1
Long-term safety and efficacy of ropeginterferon alfa-2b in Japanese patients with polycythemia vera
Keita Kirito, Yuka Sugimoto, Akihiko Gotoh, et al.
International Journal of Hematology (2024)
Open Access | Times Cited: 1
Thrombosis in myeloproliferative neoplasms: a viewpoint on its impact on myelofibrosis, mortality, and solid tumors
Tiziano Barbui, Arianna Ghirardi, Alessandra Carobbio, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Revisiting the full blood count: Circulating blood cells and their role in coagulation
Jeremy Schofield, Jun Yong, Cheng‐Hock Toh
British Journal of Haematology (2024)
Open Access
What is the optimal strategy for secondary prevention after venous thromboembolism in polycythemia vera?
Helen Ajufo, Jennifer E. Vaughn
Hematology (2024) Vol. 2024, Iss. 1, pp. 547-550
Closed Access
REVEAL puts leukocytes into risk stratification
Alberto Álvarez‐Larrán
Blood (2024) Vol. 143, Iss. 16, pp. 1561-1562
Open Access
Systemic Inflammatory Index in Polycythemia Vera and Its Prognostic Implications
Ivan Krečak, Danijela Leković, Isidora Arsenović, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 15, pp. 4459-4459
Open Access
Prognostic value of response to first-line hydroxyurea according to IPSET stratification in essential thrombocythemia
Alberto Álvarez‐Larrán, Marta Santaliestra, Marta Garrote, et al.
Research Square (Research Square) (2024)
Open Access
Impact of Phlebotomy on Quality of Life in Low-Risk Polycythemia Vera
Nathan Visweshwar, Bradley S. Fletcher, Michael Jaglal, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 16, pp. 4952-4952
Open Access
Prognostic value of response to first-line hydroxyurea according to IPSET stratification in essential thrombocythemia
Marta Santaliestra, Marta Garrote, María Soledad Noya, et al.
Leukemia (2024)
Closed Access
Ten years of experience with ruxolitinib since approval for polycythemia vera: A review of clinical efficacy and safety
Lucia Masarová, John Mascarenhas, Raajit K. Rampal, et al.
Cancer (2024)
Closed Access
Molecular and Clinical Risk Factors Associated with Thrombosis and Bleeding in Myelofibrosis Patients
Olga Morath, Carl C. Crodel, Jenny Rinke, et al.
Hämostaseologie (2024)
Closed Access
Page 1

Scroll to top